« Dr. Jan Tornell, Global Director, AstraZeneca Transgenics and Comparative Genomics, 11/30/05 | Main | Dr. Jorge Rodriguez, 2004 National Science Foundation CAREER Award recipient, and Assistant Professor of Physics, Purdue Univeresity, 11/30/05 »

December 05, 2005

Dr. Michael Liebman, Executive Director, Windber Research Institute, 11/30/05


Download Podcast

Dr. Michael Liebman is Executive Director of the Windber Research Institute. Dr. Liebman sits on 20 advisory boards, three editorial boards, and serves as a consultant to several companies. In addition, he is the author of over 60 refereed journal articles, including several on the application of bioinformatics in cancer research, as well as several books. He was named as finalist in both BioIT’s 2003 “Best Practices in Computational Research” and Genome Technology’s 2002 and 2003 “Bioinformatician of the Year.”

Dr. Liebman is currently directing seven research projects including the Alliance for Bioinformatics in Cancer’s program to establish a collaborative environment for determination of biomarkers in cancer.

The Windber Research Institute (WRI) is a world class, state-of-the-art biomedical research facility that has taken on the challenge of finding cures for genetic and metabolic diseases. Unencumbered by institutional bureaucracy, WRI has designed—from scratch—a facility for cutting edge research.

WRI collects, classifies, and stores a vast array of well-characterized biological samples, then processes and analyzes them at the cellular and molecular level to identify DNA, RNA, and proteins that are dysfunctional or inappropriately expressed. Advanced computational, biological, and bioimaging techniques are also utilized to determine how genes and proteins affect the way a disease develops and/or progresses. The information gained is then utilized in disease management and also for development of new drugs and vaccines.

WRI is well-equipped for tissue banking, molecular biology, biochemistry, immunology, cDNA microarray construction and analysis, two-dimensional gel electrophoresis of proteins, mass spectrometry, microscopy, bioimaging, laser capture microdissection, bioinformatics, and data warehousing.

Posted by David Lemberg at December 5, 2005 11:07 AM Return to SCIENCE AND SOCIETY home page